
浏览全部资源
扫码关注微信
青海大学高原医学研究中心,高原医学教育部重点实验室,青海省高原医学应用基础重点实验室,西宁 810001
张晴晴,Email:963739272@qq.com, 研究方向:慢性高原病研究。
马 兰,Email:judyml-325@163.com。
收稿:2022-12-26,
修回:2023-04-24,
录用:2023-05-23,
纸质出版:2023-07-28
移动端阅览
张晴晴,格日力,马兰.间充质干细胞外泌体对肺动脉高压治疗作用的研究进展[J].重庆医科大学学报,2023,48(7):848-852.
Zhang Qingqing,Ge Rili,Ma Lan.Research advances in the therapeutic effect of mesenchymal stem cell exosomes on pulmonary hypertension[J].Journal of Chongqing Medical University,2023,48(7):848-852.
张晴晴,格日力,马兰.间充质干细胞外泌体对肺动脉高压治疗作用的研究进展[J].重庆医科大学学报,2023,48(7):848-852. DOI: 10.13406/j.cnki.cyxb.003274.
Zhang Qingqing,Ge Rili,Ma Lan.Research advances in the therapeutic effect of mesenchymal stem cell exosomes on pulmonary hypertension[J].Journal of Chongqing Medical University,2023,48(7):848-852. DOI: 10.13406/j.cnki.cyxb.003274.
肺动脉高压(pulmonary hypertension,PH)是一种以进行性肺血管收缩、肺血管重构、右心室肥厚为特征,进而导致右心衰竭的疾病。目前治疗PH的方法仍存在很多不足,需要寻找新的治疗策略。近年来,有关间充质干细胞(mesenchymal stem cells,MSC)对PH的治疗作用及机制研究相继被国内外许多学者所重视,成为PH细胞治疗的研究热点之一。其中,MSC的旁分泌机制被认为起到一个重要的治疗作用。从MSC中分离出的外泌体(exosomes,EXO)具有抑制肺血管重构的潜力,被认为是治疗PH的一种新的潜在治疗方法。本文就MSC外泌体在PH治疗中的作用及可能机制做一综述,从而为MSC的 EXO治疗PH提供理论依据。
Pulmonary hypertension(PH) is a disease characterized by progressive pulmonary vasoconstriction, pulmonary vascular remodeling,and right ventricular hypertrophy,finally leading to right heart failure. At present,there are still insufficiencies in the treatment methods for PH, and it is needed to develop new treatment strategies. In recent years,studies have been conducted on the therapeutic effect of mesenchymal stem cells(MSC) on PH and related mechanisms by scholars in China and globally,which has become one of the research hotspots of cell therapy for PH,and among them,the paracrine mechanism of MSC is considered to have an important therapeutic effect. Exosomes(EXO) isolated from MSC have the potential to inhibit pulmonary vascular remodeling and are considered as a new potential treatment method for PH. This article reviews the role and possible mechanism of MSC EXO in the treatment of PH,so as to provide a theoretical basis for the treatment of PH by MSC EXO in the future.
Hurst LA , Dunmore BJ , Long L , et al . TNF-α drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling [J ] . Nat Commun , 2017 , 8 : 14079 .
Raquel LL , Alicia RM , Pilar ES . Pulmonary arterial hypertension [J ] . Med Clin(Barc) , 2022 , 158 ( 12 ): 622 - 629 .
David P , Jess M . Pulmonary hypertension [J ] . Ann Intern Med , 2021 , 174 ( 4 ): ITC49 - ITC64 .
叶祥琳 , 古丽胡玛 , 岳 娇 , 等 . 高原肺动脉高压的发病机制与药物治疗研究进展 [J ] . 暨南大学学报(自然科学与医学版) , 2022 , 43 ( 5 ): 467 - 479 .
Ye XL , Gu L , Yue J , et al . Research progress on the pathogenesis and pharmacological treatment of high altitude pulmonary hypertension [J ] . J Jinan Univ Nat Sci Med Ed , 2022 , 43 ( 5 ): 467 - 479 .
Alencar AKN , Pimentel-Coelho PM , Montes GC , et al . Human mesenchymal stem cell therapy reverses Su5416/hypoxia-induced pulmonary arterial hypertension in mice [J ] . Front Pharmacol , 2018 , 9 : 1395 .
Luan Y , Zhang X , Qi TG , et al . Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension [J ] . Clin Exp Med , 2014 , 14 ( 4 ): 439 - 446 .
Lamiaa A , Khaled A . New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases [J ] . Tissue Eng Regen Med , 2022 , 19 ( 6 ): 1129 - 1146 .
Kalluri R , LeBleu VS . The biology,function,and biomedical applications of exosomes [J ] . Science , 2020 , 367 ( 6478 ): eaau6977 .
Chistiakov DA , Orekhov AN , Bobryshev YV . Extracellular vesicles and atherosclerotic disease [J ] . Cell Mol Life Sci , 2015 , 72 ( 14 ): 2697 - 2708 .
Zhang XN , Sai BQ , Wang F , et al . Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT [J ] . Mol Cancer , 2019 , 18 ( 1 ): 40 .
Lopatina T , Bruno S , Tetta C , et al . Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential [J ] . Cell Commun Signal , 2014 , 12 : 26 .
Xin HQ , Li Y , Cui YS , et al . Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats [J ] . J Cereb Blood Flow Metab , 2013 , 33 ( 11 ): 1711 - 1715 .
Aliotta JM , Pereira M , Wen SC , et al . Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice [J ] . Cardiovasc Res , 2016 , 110 ( 3 ): 319 - 330 .
Lee CJ , Mitsialis SA , Aslam M , et al . Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension [J ] . Circulation , 2012 , 126 ( 22 ): 2601 - 2611 .
Mandras SA , Mehta HS , Vaidya A . Pulmonary hypertension:a brief guide for clinicians [J ] . Mayo Clin Proc , 2020 , 95 ( 9 ): 1978 - 1988 .
Zhang SS , Liu XL , Ge LL , et al . Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling [J ] . Respir Res , 2020 , 21 ( 1 ): 71 .
Klinger JR , Pereira M , Tatto MD , et al . Effect of dose,dosing intervals,and hypoxic stress on the reversal of pulmonary hypertension by mesenchymal stem cell extracellular vesicles [J ] . Pulm Circ , 2021 , 11 ( 4 ): 20458940211046137 .
Klinger JR , Pereira M , Del Tatto M , et al . Mesenchymal stem cell extracellular vesicles reverse sugen/hypoxia pulmonary hypertension in rats [J ] . Am J Respir Cell Mol Biol , 2020 , 62 ( 5 ): 577 - 587 .
Cheng SL , Shao JS , Behrmann A , et al . Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells [J ] . Arterioscler Thromb Vasc Biol , 2013 , 33 ( 7 ): 1679 - 1689 .
Ge LL , Jiang W , Zhang SS , et al . Mesenchymal stromal cell-derived exosomes attenuate experimental pulmonary arterial hypertension [J ] . Curr Pharm Biotechnol , 2021 , 22 ( 12 ): 1654 - 1662 .
Zhang ZH , Ge LL , Zhang SS , et al . The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway [J ] . J Cell Mol Med , 2020 , 24 ( 23 ): 13938 - 13948 .
Fraidenburg DR , Yuan JXJ . Hungry for more:autophagy in the pathogenesis of pulmonary arterial hypertension [J ] . Circ Res , 2013 , 112 ( 8 ): 1091 - 1093 .
Mathew R , Huang J , Shah M , et al . Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension [J ] . Circulation , 2004 , 110 ( 11 ): 1499 - 1506 .
Abernethy AD , Stackhouse K , Hart S , et al . Impact of diabetes in patients with pulmonary hypertension [J ] . Pulm Circ , 2015 , 5 ( 1 ): 117 - 123 .
Benson L , Brittain EL , Pugh ME , et al . Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension [J ] . Pulm Circ , 2014 , 4 ( 2 ): 311 - 318 .
Hogan SE , Rodriguez Salazar MP , Cheadle J , et al . Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension [J ] . Am J Physiol Lung Cell Mol Physiol , 2019 , 316 ( 5 ): L723 - L737 .
Heo JS , Lim JY , Yoon DW , et al . Exosome and melatonin additively attenuates inflammation by transferring miR-34a,miR-124,and miR-135b [J ] . Biomed Res Int , 2020 , 2020 : 1621394 .
Wang DR , Zhang H , Li M , et al . MicroRNA-124 controls the proliferative,migratory,and inflammatory phenotype of pulmonary vascular fibroblasts [J ] . Circ Res , 2014 , 114 ( 1 ): 67 - 78 .
Baglio SR , Rooijers K , Koppers-Lalic D , et al . Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species [J ] . Stem Cell Res Ther , 2015 , 6 ( 1 ): 127 .
Zhang CX , Wang PB , Mohammed A , et al . Function of adipose-derived mesenchymal stem cells in monocrotaline-induced pulmonary arterial hypertension through miR-191 via regulation of BMPR2 [J ] . Biomed Res Int , 2019 , 2019 : 2858750 .
Willis GR , Fernandez-Gonzalez A , Reis M , et al . Macrophage immunomodulation:the gatekeeper for mesenchymal stem cell derived-exosomes in pulmonary arterial hypertension? [J ] . Int J Mol Sci , 2018 , 19 ( 9 ): 2534 .
Matsuzaka Y , Yashiro R . Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine [J ] . Int J Mol Sci , 2022 , 23 ( 12 ): 6480 .
Xu JH , Liang JP , Zhu CJ , et al . Mesenchymal stem cell-derived extracellular vesicles therapy for pulmonary hypertension:a comprehensive review of preclinical studies [J ] . J Interv Cardiol , 2022 , 2022 : 5451947 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621